Trials / Sponsors / FBD Biologics Limited
FBD Biologics Limited
Industry · 3 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | An Engineered Sirpα Fused to Anti-Pd-L1 And Tgf-β Fusion Protein (HCB301) in Subjects With Selected Advanced T Advanced Solid Tumor, Refractory Hodgkin Lymphoma | Phase 1 | 2025-04-02 |
| Active Not Recruiting | Safety and Efficacy of HCB101 in Combination With Multiple Agents in Patients With Advanced Solid Tumors Solid Cancer | Phase 1 / Phase 2 | 2025-03-13 |
| Recruiting | A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematologic Advanced Solid Tumor, Refractory Non-Hodgkin Lymphoma | Phase 1 | 2023-10-02 |